litlas
ログインアカウント作成

Richard T. Silver

1958–2025 年に発表

別表記
RICHARD T. SILVER · Richard T Silver
68
論文数
21,661
被引用数
56
h 指数
68
i10 指数

被引用数

Richard T. Silver の年別被引用数1967 年: 被引用 1 件1968 年: 被引用 1 件1969 年: 被引用 3 件1970 年: 被引用 1 件1971 年: 被引用 4 件1972 年: 被引用 5 件1973 年: 被引用 6 件1974 年: 被引用 2 件1975 年: 被引用 6 件1976 年: 被引用 5 件1977 年: 被引用 9 件1978 年: 被引用 3 件1979 年: 被引用 8 件1980 年: 被引用 4 件1981 年: 被引用 6 件1982 年: 被引用 8 件1983 年: 被引用 5 件1984 年: 被引用 9 件1985 年: 被引用 5 件1986 年: 被引用 7 件1987 年: 被引用 6 件1988 年: 被引用 8 件1989 年: 被引用 9 件1990 年: 被引用 3 件1991 年: 被引用 11 件1992 年: 被引用 4 件1993 年: 被引用 6 件1994 年: 被引用 10 件1995 年: 被引用 7 件1996 年: 被引用 9 件1997 年: 被引用 5 件1998 年: 被引用 6 件1999 年: 被引用 12 件2000 年: 被引用 18 件2001 年: 被引用 20 件2002 年: 被引用 29 件2003 年: 被引用 32 件2004 年: 被引用 11 件2005 年: 被引用 11 件2006 年: 被引用 32 件2007 年: 被引用 108 件2008 年: 被引用 122 件2009 年: 被引用 163 件2010 年: 被引用 147 件2011 年: 被引用 153 件2012 年: 被引用 140 件2013 年: 被引用 192 件2014 年: 被引用 187 件2015 年: 被引用 185 件2016 年: 被引用 172 件2017 年: 被引用 134 件2018 年: 被引用 119 件2019 年: 被引用 437 件2020 年: 被引用 592 件2021 年: 被引用 547 件2022 年: 被引用 409 件2023 年: 被引用 277 件2024 年: 被引用 525 件2025 年: 被引用 192 件2026 年: 被引用 3 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,797 件、この内訳の 25.5%イタリア: 引用元論文 638 件、この内訳の 9.1%ドイツ: 引用元論文 563 件、この内訳の 8%イギリス: 引用元論文 518 件、この内訳の 7.4%フランス: 引用元論文 438 件、この内訳の 6.2%中国: 引用元論文 275 件、この内訳の 3.9%スペイン: 引用元論文 235 件、この内訳の 3.3%カナダ: 引用元論文 216 件、この内訳の 3.1%オーストラリア: 引用元論文 211 件、この内訳の 3%スイス: 引用元論文 196 件、この内訳の 2.8%オランダ: 引用元論文 162 件、この内訳の 2.3%日本: 引用元論文 141 件、この内訳の 2%
0%25.5%その他 23.4%

機関

分野

  • Medicine85.9%
  • Biochemistry, Genetics and Molecular Biology8.3%
  • Immunology and Microbiology1.8%
  • Neuroscience0.8%
  • Computer Science0.7%
  • Economics, Econometrics and Finance0.5%
  • その他2%

トピック

  • Chronic Myeloid Leukemia Treatments14%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment12.3%
  • Eosinophilic Disorders and Syndromes9%
  • Acute Myeloid Leukemia Research8.6%
  • Chronic Lymphocytic Leukemia Research6.8%
  • Kruppel-like factors research4.4%
  • その他44.9%

共著者

全論文

検索で開く
  1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    著者: Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann - Leukemia 2020 被引用: 1,510

  2. A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

    著者: Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, Iphigenia L. Koumenis, William Sun, Victor Sandor, Hagop M. Kantarjian - New England Journal of Medicine 2012 被引用: 2,050

  3. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

    著者: Brian Druker, François Guilhot, Stephen G. O’Brien, Insa Gathmann, Hagop M. Kantarjian, Norbert Gattermann, Michael W. Deininger, Richard T. Silver, John M. Goldman, Richard M. Stone, Francisco Cervantes, Andreas Hochhaus, Bayard L. Powell, Janice Gabrilove, Philippe Rousselot, Josy Reiffers, Jan J. Cornelissen, Timothy P. Hughes, Hermine Agis, Thomas Fischer, Gregor Verhoef, John D. Shepherd, Giuseppe Saglio, Aloïs Gratwohl, Johan Lanng Nielsen, Jerald P. Radich, Bengt Simonsson, Kerry Taylor, Michele Baccarani, Charlene So, Laurie Letvak, Richard A. Larson - New England Journal of Medicine 2006 被引用: 3,481

  4. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

    著者: Tiziano Barbui, Ayalew Tefferi, Alessandro M. Vannucchi, Francesco Passamonti, Richard T. Silver, Ronald Hoffman, Srđan Verstovšek, Ruben A. Mesa, Jean‐Jacques Kiladjian, Rȕdiger Hehlmann, Andreas Reiter, Francisco Cervantes, Claire Harrison, Mary Frances Mc Mullin, Hans Carl Hasselbalch, Steffen Koschmieder, Monia Marchetti, Andrea Bacigalupo, Guido Finazzi, Nicolaus Kröger, Martin Grießhammer, Gunnar Birgegård, Giovanni Barosi - Leukemia 2018 被引用: 552

  5. Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

    著者: for the COMFORT-I investigators, Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Mark M. Jones, Deanna Kornacki, Kang Sun, Hagop M. Kantarjian - Journal of Hematology & Oncology 2017 被引用: 427

  6. A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

    著者: John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N. Harrison, Mary Frances McMullin, Alessandro M. Vannucchi, Joanne Ewing, Casey L. O'Connell, Jean-Jacques Kiladjian, Adam J. Mead, Elliott F. Winton, David S. Leibowitz, Valerio De Stefano, Murat O. Arcasoy, Craig M. Kessler, Rosalind Catchatourian, Damiano Rondelli, Richard T. Silver, Andrea Bacigalupo, Arnon Nagler, Marina Kremyanskaya, Max F. Levine, Juan E. Arango Ossa, Erin McGovern, Lonette Sandy, Mohamad E. Salama, Vesna Najfeld, Joseph Tripodi, Noushin Farnoud, Alexander V. Penson, Rona Singer Weinberg, Leah Price, Judith D. Goldberg, Tiziano Barbui, Roberto Marchioli, Gianni Tognoni, Raajit K. Rampal, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman - Blood 2022 被引用: 129

  7. Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

    著者: Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Ramón V. Tiu, Pierre Zachée, Éric Jourdan, Elliott F. Winton, Richard T. Silver, Harry C. Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Joanne Lager, Zhenming Shun, Ruben A. Mesa - The Lancet Haematology 2017 被引用: 330

  8. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

    著者: Francesco Passamonti, Toni Giorgino, Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S. Komrokji, Jason Gotlib, Jean‐Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T. Silver, Giulia Benevolo, Francesco Albano, Domenica Caramazza, Michele Merli, Daniela Pietra, Rosario Casalone, Giada Rotunno, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi - Leukemia 2017 被引用: 334

  9. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    著者: Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong‐Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman, Rüdiger Hehlmann - Blood 2013 被引用: 1,989

  10. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms

    著者: Angela G. Fleischman, Karl J. Aichberger, Samuel B. Luty, Thomas G.P. Bumm, Curtis L. Petersen, Shirin Doratotaj, Kavin B. Vasudevan, Dorian LaTocha, Fei Yang, Richard D. Press, Marc Loriaux, Heike L. Pahl, Richard T. Silver, Anupriya Agarwal, Thomas O’Hare, Brian Druker, Grover C. Bagby, Michael W. Deininger - Blood 2011 被引用: 287

  11. Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations

    著者: Monia Marchetti, Alessandro Maria Vannucchi, Martin Griesshammer, Claire Harrison, Steffen Koschmieder, Heinz Gisslinger, Alberto Álvarez-Larrán, Valerio De Stefano, Paola Guglielmelli, Francesca Palandri, Francesco Passamonti, Giovanni Barosi, Richard T Silver, Rüdiger Hehlmann, Jean-Jacques Kiladjian, Tiziano Barbui - The Lancet Haematology 2022 被引用: 113

  12. Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

    著者: Ghaith Abu‐Zeinah, Spencer Krichevsky, Tatiana Cruz, Gabriela Hoberman, Diana Jaber, Niamh Savage, Claudia Sosner, Ellen K. Ritchie, Joseph M. Scandura, Richard T. Silver - Leukemia 2021 被引用: 109

  13. Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia

    著者: Ehab Atallah, Charles A. Schiffer, Jerald P. Radich, Kevin P. Weinfurt, Mei-Jie Zhang, Javier Pinilla‐Ibarz, Vamsi Kota, Richard A. Larson, Joseph O. Moore, Michael J. Mauro, Michael W. Deininger, James E. Thompson, Vivian G. Oehler, Martha Wadleigh, Neil P. Shah, Ellen K. Ritchie, Richard T. Silver, Jörge E. Cortes, Li Lin, Alexis Visotcky, Arielle Baim, Jill Harrell, Bret Helton, Mary M. Horowitz, Kathryn E. Flynn - JAMA Oncology 2020 被引用: 105

  14. Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

    著者: Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, Josef T. Prchal, Dmitry Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Elliott F. Winton, Maria Chiara Finazzi, Alessandro Rambaldi, Alessandro M. Vannucchi, D Leibowitz, Damiano Rondelli, Murat O. Arcasoy, Rosalind Catchatourian, Joseph Vadakara, Vittorio Rosti, Elizabeth O. Hexner, Marina Kremyanskaya, Lonette Sandy, Joseph Tripodi, Vesna Najfeld, Noushin Farnoud, Elli Papaemmanuil, Mohamed E. Salama, Rona Singer-Weinberg, Raajit K. Rampal, Judith D. Goldberg, Tiziano Barbui, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman - Blood 2019 被引用: 171

  15. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

    著者: Steffen Koschmieder, Tariq I. Mughal, Hans Carl Hasselbalch, Giovanni Barosi, Peter Valent, J-J Kiladjian, Georg Jeryczynski, Heinz Gisslinger, Jonas S. Jutzi, Heike L. Pahl, Rüdiger Hehlmann, Alessandro M. Vannucchi, Francisco Cervantes, Richard T. Silver, Tiziano Barbui - Leukemia 2016 被引用: 167

  16. Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure

    著者: Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Éric Jourdan, Richard T. Silver, Harry C. Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srđan Verstovšek, Shelonitda Rose, Juan Shen, Tymara Berry, Carrie Brownstein, Ruben A. Mesa - American Journal of Hematology 2020 被引用: 148

  17. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    著者: Michele Baccarani, Jörge E. Cortes, Fabrizio Pane, Dietger Niederwieser, Giuseppe Saglio, Jane F. Apperley, Francisco Cervantes, Michael W. Deininger, Aloïs Gratwohl, François Guilhot, Andreas Hochhaus, Mary M. Horowitz, Timothy P. Hughes, Hagop M. Kantarjian, Richard A. Larson, Jerald P. Radich, Bengt Simonsson, Richard T. Silver, John M. Goldman, Rüdiger Hehlmann - Journal of Clinical Oncology 2009 被引用: 1,298

  18. Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    著者: Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård, Francisco Cervantes, Guido Finazzi, Martin Grießhammer, Claire Harrison, Hans Carl Hasselbalch, Rüdiger Hehlmann, Ronald Hoffman, Jean‐Jacques Kiladjian, Nicolaus Kröger, Ruben A. Mesa, Mary Frances McMullin, Animesh Pardanani, Francesco Passamonti, Alessandro M. Vannucchi, Andreas Reiter, Richard T. Silver, Srđan Verstovšek, Ayalew Tefferi - Journal of Clinical Oncology 2011 被引用: 834

  19. In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in mice

    著者: Thom P. Santisakultarm, Nathan R. Cornelius, Nozomi Nishimura, Andrew I. Schafer, Richard T. Silver, Peter C. Doerschuk, William L. Olbricht, Chris B. Schaffer - American Journal of Physiology-Heart and Circulatory Physiology 2012 被引用: 165

  20. New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

    著者: Hans C. Hasselbalch, Richard T. Silver - HemaSphere 2021 被引用: 34

  21. Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm–Associated Pulmonary Hypertension

    著者: Jiwon Kim, Spencer Krichevsky, Lola Xie, Maria Chiara Palumbo, Sara Rodríguez Diego, Brian Yum, Lillian R. Brouwer, Richard T. Silver, Andrew I. Schafer, Ellen K. Ritchie, Maria Mia Yabut, Claudia Sosner, Evelyn M. Horn, Richard B. Devereux, Joseph M. Scandura, Jonathan W. Weinsaft - Journal of the American Society of Echocardiography 2019 被引用: 24

  22. Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia

    著者: Neil P. Shah, Hagop M. Kantarjian, Dong‐Wook Kim, Delphine Réa, Pedro Enrique Dorlhiac‐Llacer, Jorge Milone, Jorge Vela‐Ojeda, Richard T. Silver, H. Jean Khoury, Aude Charbonnier, Н Д Хорошко, Ronald Paquette, Michael W. Deininger, Robert H. Collins, I. Rodríguez-M. Otero, Timothy P. Hughes, Eric Bleickardt, Lewis C. Strauss, Stephen Francis, Andreas Hochhaus - Journal of Clinical Oncology 2008 被引用: 488

  23. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT)

    著者: Ruben A. Mesa, Srđan Verstovšek, Francisco Cervantes, Giovanni Barosi, John T. Reilly, Brigitte Dupriez, Ross L. Levine, Marie‐Caroline Le Bousse‐Kerdilès, Martha Wadleigh, Peter J. Campbell, Richard T. Silver, Alessandro M. Vannucchi, H. Joachim Deeg, Heinz Gisslinger, Deborah A. Thomas, Olatoyosi Odenike, Lawrence A. Solberg, Jason Gotlib, Elizabeth O. Hexner, Stephen D. Nimer, Hagop M. Kantarjian, Attilio Orazi, James W. Vardiman, Jüergen Thiele, Ayalew Tefferi - Leukemia Research 2007 被引用: 321

  24. Normal life expectancy for polycythemia vera (PV) patients is possible

    著者: Ghaith Abu‐Zeinah, Richard T. Silver, Khalid Abu-Zeinah, Joseph M. Scandura - Leukemia 2021 被引用: 42